Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Free Cash Flow To Equity

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Free-Cash-Flow-To-Equity" stands at 0.0127 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 06/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.5053 Trillion Japanese Yens compared to the value the year prior.
The 1 year change is -0.5053 Trillion Japanese Yens.
The 3 year change is -0.5945 Trillion Japanese Yens.
The 5 year change is -0.3022 Trillion Japanese Yens.
The 10 year change is 0.1916 Trillion Japanese Yens.

The Serie's long term average value is 0.269 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is -0.256 Trillion Japanese Yens lower, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is +0.6635 Trillion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2019, to it's latest available value, on 09/30/2025, is -3.41 Trillion.

Free Cash Flow To Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Free Cash Flow To Equity905,699,262,464.00
LogoJohnson & Johnson - Free Cash Flow To Equity486,508,953,600.00
LogoAbbVie Inc - Free Cash Flow To Equity399,570,305,024.00
LogoRoche Holding AG - Free Cash Flow To Equity317,433,206,677.55
LogoAstraZeneca PLC - Free Cash Flow To Equity280,205,508,085.11